Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Raptis

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|October 24, 2002
Neo-adjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancerPaolo Alberto Paciucci, George Raptis, Ira Bleiweiss, et al.
Analytical Chemistry|November 20, 2010
Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometryMalgorzata Jaremko, Yumi Kasai, Myra F Barginear, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancerKatherine D Crew, Heather Greenlee, Jillian Capodice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Identification of mammaglobin as a novel serum marker for breast cancerJonine L Bernstein, James H Godbold, George Raptis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Racial disparities in treatment and survival of male breast cancerKatherine D Crew, Alfred I Neugut, Xiaoyan Wang, et al.
Journal of Cancer Survivorship : Research and Practice|July 24, 2008
Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patientsKatherine D Crew, Jillian L Capodice, Heather Greenlee, et al.
Journal of Cancer|August 18, 2021
Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with <i>De Novo</i> Stage IV Breast CancerTakeo Fujii, Hasan Rehman, Su Yun Chung, et al.
Nature|July 16, 2025
Neutrophils drive vascular occlusion, tumour necrosis and metastasisJose M Adrover, Xiao Han, Lijuan Sun, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
The Oncologist|June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|October 24, 2002
Neo-adjuvant therapy with dose-dense docetaxel plus short-term filgrastim rescue for locally advanced breast cancerPaolo Alberto Paciucci, George Raptis, Ira Bleiweiss, et al.
Analytical Chemistry|November 20, 2010
Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometryMalgorzata Jaremko, Yumi Kasai, Myra F Barginear, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancerKatherine D Crew, Heather Greenlee, Jillian Capodice, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Identification of mammaglobin as a novel serum marker for breast cancerJonine L Bernstein, James H Godbold, George Raptis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Racial disparities in treatment and survival of male breast cancerKatherine D Crew, Alfred I Neugut, Xiaoyan Wang, et al.
Journal of Cancer Survivorship : Research and Practice|July 24, 2008
Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patientsKatherine D Crew, Jillian L Capodice, Heather Greenlee, et al.
Journal of Cancer|August 18, 2021
Treatment with Granulocyte-colony Stimulating Factor (G-CSF) is not associated with Increased Risk of Brain Metastasis in Patients with <i>De Novo</i> Stage IV Breast CancerTakeo Fujii, Hasan Rehman, Su Yun Chung, et al.
Nature|July 16, 2025
Neutrophils drive vascular occlusion, tumour necrosis and metastasisJose M Adrover, Xiao Han, Lijuan Sun, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
The Oncologist|June 7, 2023
Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)Rudolph M Navari, Jennifer Le-Rademacher, Fabrice Smieliauskas, et al.
Pageof 3